Annual report pursuant to Section 13 and 15(d)

Basis of Presentation, Summary of Significant Accounting Policies (Schedule of Antidilutive Securities) (Details)

v3.22.0.1
Basis of Presentation, Summary of Significant Accounting Policies (Schedule of Antidilutive Securities) (Details) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares not included in the computation of EPS 4,080,345 2,711,274 5,114,955
Warrants to purchase common stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares not included in the computation of EPS 63,000 2,061,770 3,574,257
Option to purchase common stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares not included in the computation of EPS 12,000 12,000
Unvested restricted stock awards [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares not included in the computation of EPS 4,015,146 633,305 1,524,499
Convertible Preferred Stock Series B [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares not included in the computation of EPS 2,199 4,199 4,199